Teva Pharmaceuticals USA, Inc.

NJ · United States · Reporting entity ID 100000000141

Total reported 2019–2025

$357.5M

#44 of 2,960 reporting companies — 0.4% of all reported industry payments

$81.0M in general payments across 806,538 records, plus $276.5M in research funding across 42,986 records.

How it breaks down

General payments $80,954,205

Research funding $276,495,895

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.